Özge Karaosmanoğlu
Research Subjects
Özge Karaosmanoğlu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ayşen Yücetürk
Acıbadem Maslak Hospital, In Vitro Fertilization Center, İstanbul, Türkiye
11 shared publications - Bülent Tıraş
Acıbadem Mehmet Ali Aydınlar University School of Medicine, Department of Obstetrics & Gynecology and Reproductive Endocrinology, İstanbul, Türkiye
11 shared publications - Ilke Ozer Aslan
Tekirdağ Namık Kemal University Faculty of Medicine, Department of Obstetrics and Gynecology, Tekirdağ, Türkiye
6 shared publications - Nuri Peker
Acıbadem Maslak Hospital, In Vitro Fertilization Center, İstanbul, Türkiye
6 shared publications - Burak Elmas
Department of Obstetrics and Gynecology Ankara Bilkent City Hospital Ankara Turkey
5 shared publications - Yigit Cakiroglu
Acıbadem Maslak Hospital Assisted Reproductive Technologies Unit, İstanbul, Turkey
5 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Evaluating progestin-primed and GnRH antagonist ovarian stimulation protocols in PGT-A cycles: implications for clinical practice
Progestin-primed ovarian stimulation (PPOS) has emerged as an alternative to GnRH-antagonist protocols in IVF, yet its impact on embryo chromosomal competence remains controversial. Evidence is particularly limited regarding whether PPOS influences blastocyst euploidy rates and key clinical outcomes in PGT-A cycles, and whether these effects vary according to maternal age and ovarian reserve status. This retrospective cohort study included 1,843 PGT-A cycles (666 PPOS, 1,177 GnRH antagonist) performed at a single tertiary IVF center between January 2016 and January 2024. Controlled ovarian stimulation was performed with either oral medroxyprogesterone acetate or daily cetrorelix, followed by vitrification of all biopsied blastocysts and subsequent frozen embryo transfer. Primary outcomes were blastocyst euploidy and clinical pregnancy rates. Secondary outcomes included embryological parameters, miscarriage, live birth, and cumulative pregnancy rates. Subgroup analyses were performed according to maternal age and ovarian reserve. The mean age was 37.64±4.48 years in the PPOS group and 37.80±3.49 years in the GnRH-antagonist group; age and other baseline characteristics were comparable between groups. PPOS cycles had a shorter stimulation duration (median 8 vs. 9 days, p = 0.001), with comparable gonadotropin requirements and embryological outcomes. Euploidy (32.6% vs. 32.1%, p = 0.653), mosaicism, and aneuploidy rates did not differ significantly. Clinical pregnancy, live birth, and cumulative pregnancy rates were equivalent. PPOS and GnRH antagonist protocols yield comparable embryological and clinical outcomes in PGT-A cycles, including in advanced maternal age and diminished ovarian reserve subgroups. With its shorter stimulation duration and cost-effectiveness, PPOS is a valid alternative when fresh transfer is not planned.
- 30 June 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessEvaluating progestin-primed and GnRH antagonist ovarian stimulation protocols in PGT-A cycles: implications for clinical practice
Progestin-primed ovarian stimulation (PPOS) has emerged as an alternative to GnRH-antagonist protocols in IVF, yet its impact on embryo chromosomal competence remains controversial. Evidence is particularly limited regarding whether PPOS influences blastocyst euploidy rates and key clinical outcomes in PGT-A cycles, and whether these effects vary according to maternal age and ovarian reserve status. This retrospective cohort study included 1,843 PGT-A cycles (666 PPOS, 1,177 GnRH antagonist) performed at a single tertiary IVF center between January 2016 and January 2024. Controlled ovarian stimulation was performed with either oral medroxyprogesterone acetate or daily cetrorelix, followed by vitrification of all biopsied blastocysts and subsequent frozen embryo transfer. Primary outcomes were blastocyst euploidy and clinical pregnancy rates. Secondary outcomes included embryological parameters, miscarriage, live birth, and cumulative pregnancy rates. Subgroup analyses were performed according to maternal age and ovarian reserve. The mean age was 37.64±4.48 years in the PPOS group and 37.80±3.49 years in the GnRH-antagonist group; age and other baseline characteristics were comparable between groups. PPOS cycles had a shorter stimulation duration (median 8 vs. 9 days, p = 0.001), with comparable gonadotropin requirements and embryological outcomes. Euploidy (32.6% vs. 32.1%, p = 0.653), mosaicism, and aneuploidy rates did not differ significantly. Clinical pregnancy, live birth, and cumulative pregnancy rates were equivalent. PPOS and GnRH antagonist protocols yield comparable embryological and clinical outcomes in PGT-A cycles, including in advanced maternal age and diminished ovarian reserve subgroups. With its shorter stimulation duration and cost-effectiveness, PPOS is a valid alternative when fresh transfer is not planned.
- Open Access
- 5 March 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 81-87
Inverted microscopy as a high performance tool for pre denudation evaluation of oocyte nuclear maturity
Inverted microscopy as a high performance tool for pre denudation evaluation of oocyte nuclear maturity - Turkish Journal of Obstetrics and Gynecology
- 5 March 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 81-87
Open AccessInverted microscopy as a high performance tool for pre denudation evaluation of oocyte nuclear maturity
Inverted microscopy as a high performance tool for pre denudation evaluation of oocyte nuclear maturity - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 5 March 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 95-100
Inverted microscopy-based assessment reveals major maturation gap between denuded and non-denuded GV oocytes: A novel r-IVM approach
Inverted microscopy-based assessment reveals major maturation gap between denuded and non-denuded GV oocytes: A novel r-IVM approach - Turkish Journal of Obstetrics and Gynecology
- 5 March 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 95-100
Open AccessInverted microscopy-based assessment reveals major maturation gap between denuded and non-denuded GV oocytes: A novel r-IVM approach
Inverted microscopy-based assessment reveals major maturation gap between denuded and non-denuded GV oocytes: A novel r-IVM approach - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 29 January 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 64-70
The relationship between oocyte maturation and follicle size: A comparative analysis of 2D and 3D ultrasound
The relationship between oocyte maturation and follicle size: A comparative analysis of 2D and 3D ultrasound - Turkish Journal of Obstetrics and Gynecology
- 29 January 2026
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 23 (1) , 64-70
Open AccessThe relationship between oocyte maturation and follicle size: A comparative analysis of 2D and 3D ultrasound
The relationship between oocyte maturation and follicle size: A comparative analysis of 2D and 3D ultrasound - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 5 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0340292
Do hypoechoic endometrial cystic appearances before embryo transfer affect pregnancy rates in frozen-thawed cycles?
Background: The presence of hypoechoic cystic lesions (HCL) within the endometrium has been proposed as a potential factor influencing implantation and pregnancy outcomes during frozen–thawed embryo transfer (FET) cycles. However, evidence regarding their clinical significance remains limited and inconsistent. This study aimed to evaluate the effect of endometrial HCLs detected by transvaginal sonography on pregnancy and live-birth outcomes in women undergoing FET. Materials and Methods: This retrospective study included 88 women undergoing hormone replacement therapy–FET cycles, divided into two groups: patients with HCLs ( n = 44) and controls with a normal trilaminar endometrial pattern ( n = 44). The primary outcome was the live birth rate (LBR), which represents the most clinically meaningful endpoint of treatment success. Secondary outcomes included the clinical pregnancy rate (CPR) and miscarriage rate, while HCL size was analyzed as a secondary exploratory variable to assess potential associations with IVF outcomes. Results: There were no significant differences between groups in age, body mass index, duration of infertility, or endometrial thickness. The groups were also comparable regarding infertility cause, embryo-transfer day, and number of embryos transferred. The LBR, the primary outcome, was 52.3% in the HCL group and 50.0% in controls ( p = 0.670; OR = 1.10, 95% CI 0.47–2.53). Clinical pregnancy occurred in 68.2% of patients in both groups ( p = 1.000), and biochemical pregnancy in 4.5% vs 2.3% ( p = 1.000). Miscarriage rates were 20.5% and 15.9%, respectively ( p = 1.000). No significant association was found between HCL size and any reproductive outcome. Conclusion: Hypoechoic cystic lesions within the endometrium do not appear to adversely affect pregnancy or live-birth outcomes in FET cycles when adequate endometrial thickness (≥7 mm) and a trilaminar pattern are present.
- 5 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0340292
Open AccessDo hypoechoic endometrial cystic appearances before embryo transfer affect pregnancy rates in frozen-thawed cycles?
Background: The presence of hypoechoic cystic lesions (HCL) within the endometrium has been proposed as a potential factor influencing implantation and pregnancy outcomes during frozen–thawed embryo transfer (FET) cycles. However, evidence regarding their clinical significance remains limited and inconsistent. This study aimed to evaluate the effect of endometrial HCLs detected by transvaginal sonography on pregnancy and live-birth outcomes in women undergoing FET. Materials and Methods: This retrospective study included 88 women undergoing hormone replacement therapy–FET cycles, divided into two groups: patients with HCLs ( n = 44) and controls with a normal trilaminar endometrial pattern ( n = 44). The primary outcome was the live birth rate (LBR), which represents the most clinically meaningful endpoint of treatment success. Secondary outcomes included the clinical pregnancy rate (CPR) and miscarriage rate, while HCL size was analyzed as a secondary exploratory variable to assess potential associations with IVF outcomes. Results: There were no significant differences between groups in age, body mass index, duration of infertility, or endometrial thickness. The groups were also comparable regarding infertility cause, embryo-transfer day, and number of embryos transferred. The LBR, the primary outcome, was 52.3% in the HCL group and 50.0% in controls ( p = 0.670; OR = 1.10, 95% CI 0.47–2.53). Clinical pregnancy occurred in 68.2% of patients in both groups ( p = 1.000), and biochemical pregnancy in 4.5% vs 2.3% ( p = 1.000). Miscarriage rates were 20.5% and 15.9%, respectively ( p = 1.000). No significant association was found between HCL size and any reproductive outcome. Conclusion: Hypoechoic cystic lesions within the endometrium do not appear to adversely affect pregnancy or live-birth outcomes in FET cycles when adequate endometrial thickness (≥7 mm) and a trilaminar pattern are present.
- Open Access
- 3 September 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (3) , 194-198
Prediction of oocyte maturity before denudation: Is the assessment of COC morphology a reliable option?
Prediction of oocyte maturity before denudation: Is the assessment of COC morphology a reliable option? - Turkish Journal of Obstetrics and Gynecology
- 3 September 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (3) , 194-198
Open AccessPrediction of oocyte maturity before denudation: Is the assessment of COC morphology a reliable option?
Prediction of oocyte maturity before denudation: Is the assessment of COC morphology a reliable option? - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 8 April 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-6
Why should we check the tubes in IVF patients with ovarian endometriosis before embryo transfer? a retrospective study
The endometrioma accompanying hydrosalpinx can affect the success rate of in vitro fertilization (IVF). We aimed to determine the incidence of hydrosalpinx in infertile patients with endometrioma and its effects on in vitro fertilization success. In our retrospective study, we performed hysterosalpingography (HSG) on patients diagnosed with endometrioma through ultrasound evaluation. Then, we performed diagnostic laparoscopy on patients with suspected tubal pathology and/or hydrosalpinx after HSG assessment. Laparoscopic tubal occlusion was performed for patients with hydrosalpinx. HSG was performed on 760 patients diagnosed with ovarian endometriosis. After the assessment of HSG images, hydrosalpinx was detected in 184 of 760 patients (24.2%) and diagnostic laparoscopy was performed. Unilateral or bilateral hydrosalpinx were detected at 65 of 184 (35.3%) patients. Laparoscopy and proximal tubal occlusion were performed in these patients. Incidence of hydrosalpinx was found to be 8.5% in IVF patients with ovarian endometrioma. Tubal patency screening may be considered for the patients with endometrioma before embryo transfer to prevent IVF failure due to hydrosalpinx.
- 8 April 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-6
Open AccessWhy should we check the tubes in IVF patients with ovarian endometriosis before embryo transfer? a retrospective study
The endometrioma accompanying hydrosalpinx can affect the success rate of in vitro fertilization (IVF). We aimed to determine the incidence of hydrosalpinx in infertile patients with endometrioma and its effects on in vitro fertilization success. In our retrospective study, we performed hysterosalpingography (HSG) on patients diagnosed with endometrioma through ultrasound evaluation. Then, we performed diagnostic laparoscopy on patients with suspected tubal pathology and/or hydrosalpinx after HSG assessment. Laparoscopic tubal occlusion was performed for patients with hydrosalpinx. HSG was performed on 760 patients diagnosed with ovarian endometriosis. After the assessment of HSG images, hydrosalpinx was detected in 184 of 760 patients (24.2%) and diagnostic laparoscopy was performed. Unilateral or bilateral hydrosalpinx were detected at 65 of 184 (35.3%) patients. Laparoscopy and proximal tubal occlusion were performed in these patients. Incidence of hydrosalpinx was found to be 8.5% in IVF patients with ovarian endometrioma. Tubal patency screening may be considered for the patients with endometrioma before embryo transfer to prevent IVF failure due to hydrosalpinx.
- Open Access
- 10 March 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 35-40
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study - Turkish Journal of Obstetrics and Gynecology
- 10 March 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (1) , 35-40
Open AccessEffects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study
Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 12 December 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (4) , 266-272
The effect of gonadotropin gap for non-growing follicles in poor ovarian response: Might this be a new strategy?
Cessation of gonadotropin stimulation might affect follicular growth in patients in POSEIDON groups 3 and 4, which are unresponsive to high-dose stimulation. In this retrospective study, data were extracted from the medical records of patients treated at the Acıbadem Maslak Hospital Assisted Reproductive Technologies Unit between November 2010 and December 2020. Eighty-five patients who fulfilled the inclusion criteria were included in the study. Gonadotropin stimulation was discontinued if the follicle diameter increased by 2 mm within 7 days after the initiation of stimulation in patients in groups 3 and 4. The outcomes of the treatment strategy and pregnancy were recorded. Follicular growth was observed in 40% (34/85) of patients, of whom 52.9% (18/34) had 2pn embryos. Ten of the 85 patients (11.8%) underwent embryo transfer, resulting in biochemical pregnancy for two patients and healthy live birth for one patient. When high-dose stimulation is ineffective, discontinuing gonadotropin administration during ovarian stimulation may provide patients with the opportunity to conceive using their own biological oocytes. To the best of our knowledge, this is the first study to report a live birth rate using this strategy.
- 12 December 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (4) , 266-272
Open AccessThe effect of gonadotropin gap for non-growing follicles in poor ovarian response: Might this be a new strategy?
Cessation of gonadotropin stimulation might affect follicular growth in patients in POSEIDON groups 3 and 4, which are unresponsive to high-dose stimulation. In this retrospective study, data were extracted from the medical records of patients treated at the Acıbadem Maslak Hospital Assisted Reproductive Technologies Unit between November 2010 and December 2020. Eighty-five patients who fulfilled the inclusion criteria were included in the study. Gonadotropin stimulation was discontinued if the follicle diameter increased by 2 mm within 7 days after the initiation of stimulation in patients in groups 3 and 4. The outcomes of the treatment strategy and pregnancy were recorded. Follicular growth was observed in 40% (34/85) of patients, of whom 52.9% (18/34) had 2pn embryos. Ten of the 85 patients (11.8%) underwent embryo transfer, resulting in biochemical pregnancy for two patients and healthy live birth for one patient. When high-dose stimulation is ineffective, discontinuing gonadotropin administration during ovarian stimulation may provide patients with the opportunity to conceive using their own biological oocytes. To the best of our knowledge, this is the first study to report a live birth rate using this strategy.
- Open Access
- 4 September 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (3) , 135-141
Might retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger?
Might retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger? - Turkish Journal of Obstetrics and Gynecology
- 4 September 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (3) , 135-141
Open AccessMight retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger?
Might retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger? - Turkish Journal of Obstetrics and Gynecology